Figure Technology Solutions Inc. Class A Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? Figure Technology Solutions Inc. Class A Common Stock trades at $28.02 (market cap $6.21B), while Revolution Medicines Inc. Common Stock trades at $189 (market cap $43.07B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 6.9× Figure Technology Solutions Inc. Class A Common Stock's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, Figure Technology Solutions Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Figure Technology Solutions Inc. Class A Common Stock for 0 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| FIGR | RVMD | |
|---|---|---|
Market Cap | $6.21B | $43.07B |
Volume | 4,025,182 | 1,184,841 |
Sector | Financials | Health |
52-Week High | $73.91 | $221.15 |
52-Week Low | $24.91 | $47.50 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.24B | $39.77B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Figure Technology Solutions operates a blockchain-native capital marketplace. Its platform supports loan origination, funding, sale, and trading of tokenized assets, along with digital-asset infrastructure and services.
Read more on FIGR →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →